146 related articles for article (PubMed ID: 30035467)
21. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
Yuta A; Miyamoto Y; Ogihara H; Hattori R; Okubo K
Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
[TBL] [Abstract][Full Text] [Related]
22. A randomized double-blind comparative study of sublingual immunotherapy for cedar pollinosis.
Okubo K; Gotoh M; Fujieda S; Okano M; Yoshida H; Morikawa H; Masuyama K; Okamoto Y; Kobayashi M
Allergol Int; 2008 Sep; 57(3):265-75. PubMed ID: 18566549
[TBL] [Abstract][Full Text] [Related]
23. [EFFICACY AND SAFETY OF PEDIATRIC SUBLINGUAL IMMMUNOTHERAPY WITH CEDARCURE
Yuta A; Ogawa Y; Suzuki Y; Ogihara H; Kozaki H; Shimizu T
Arerugi; 2020; 69(9):909-917. PubMed ID: 33191379
[TBL] [Abstract][Full Text] [Related]
24. Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy.
Otsuka K; Otsuka H; Matsune S; Okubo K
Immun Inflamm Dis; 2020 Sep; 8(3):333-341. PubMed ID: 32468704
[TBL] [Abstract][Full Text] [Related]
25. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of sublingual immunotherapy for cedar pollinosis: A systematic review and meta-analysis.
Yang Y; Zhou W; Chen A
Ann Allergy Asthma Immunol; 2016 Oct; 117(4):348-353. PubMed ID: 27566862
[TBL] [Abstract][Full Text] [Related]
27. Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in 2-year sublingual immunotherapy (SLIT) for Japanese cedar pollinosis.
Fujimura T; Yonekura S; Horiguchi S; Taniguchi Y; Saito A; Yasueda H; Inamine A; Nakayama T; Takemori T; Taniguchi M; Sakaguchi M; Okamoto Y
Clin Immunol; 2011 Apr; 139(1):65-74. PubMed ID: 21300571
[TBL] [Abstract][Full Text] [Related]
28. Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen.
Ueda S; Ito J; Harada N; Harada S; Sasano H; Sandhu Y; Tanabe Y; Abe S; Shiota S; Kodama Y; Nagaoka T; Makino F; Chiba A; Akiba H; Atsuta R; Miyake S; Takahashi K
Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454107
[TBL] [Abstract][Full Text] [Related]
29. The Combined Effects of Sublingual Immunotherapy and Lactobacillus acidophilus-Producing Extract on Cedar Pollinosis Symptoms.
Hirobumi I; Sasuga Y
Cureus; 2023 Jul; 15(7):e41374. PubMed ID: 37408939
[TBL] [Abstract][Full Text] [Related]
30. Effect of Japanese cedar-specific sublingual immunotherapy on allergen-specific TH2 cell counts in blood.
Nomura T; Suzuki M; Yokota M; Nakamura Y; Ozeki K; Ito Y; Tsuge I; Saitoh S
Ann Allergy Asthma Immunol; 2016 Jul; 117(1):72-78.e4. PubMed ID: 27156747
[TBL] [Abstract][Full Text] [Related]
31. [ANALYSIS OF BACKGROUNDS AND LEVEL OF UNDERSTANDING OF TREATMENT OF POOR ADHERENCE AND DROPOUT CASES ON SUBLINGUAL IMMUNOTHERAPY FOR JAPANESE CEDAR POLLINOSIS IN THE FIRST FOLLOW-UP YEAR].
Kikkawa S; Kamijo A; Nakagome K; Soma T; Kobayashi T; Uchida Y; Morita E; Nagata M; Inoue T; Kase Y
Arerugi; 2017; 66(9):1165-1171. PubMed ID: 29129887
[TBL] [Abstract][Full Text] [Related]
32. Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis.
Kikuoka H; Kouzaki H; Matsumoto K; Arai H; Yamamoto S; Tojima I; Shimizu S; Miyashita H; Ogawa Y; Osada T; Okano M; Yuta A; Shimizu T
Clin Immunol; 2020 Jan; 210():108310. PubMed ID: 31743749
[TBL] [Abstract][Full Text] [Related]
33. Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress.
Yonekura S; Gotoh M; Okano M; Kurokawa T; Maekawa Y; Okubo K; Okamoto Y
Allergol Int; 2022 Jan; 71(1):140-143. PubMed ID: 34509370
[No Abstract] [Full Text] [Related]
34. Preliminary Clinical Trial of Biomarkers to Predict Response to Sublingual Immunotherapy for Japanese Cedar Pollinosis.
Takahara E; Matsune S; Ishida M; Wakayama N; Okubo K
J Nippon Med Sch; 2020 Dec; 87(5):277-284. PubMed ID: 32074537
[TBL] [Abstract][Full Text] [Related]
35. [The enhanced clinical efficacy by treated years and the sustained efficacy after treatment of sublingual immunotherapy for Japanese cedar pollinosis].
Yuta A; Ogihara H; Miyamoto Y; Takeuchi K; Okubo K
Arerugi; 2010 Nov; 59(11):1552-61. PubMed ID: 21119301
[TBL] [Abstract][Full Text] [Related]
36. Disease-Modifying Effect of Japanese Cedar Pollen Sublingual Immunotherapy Tablets.
Yonekura S; Gotoh M; Kaneko S; Maekawa Y; Okubo K; Okamoto Y
J Allergy Clin Immunol Pract; 2021 Nov; 9(11):4103-4116.e14. PubMed ID: 34333190
[TBL] [Abstract][Full Text] [Related]
37. [Adverse Events of Sublingual Immunotherapy in 207 Patients with Japanese Cedar Pollinosis].
Ogawa Y; Yuta A; Arikata M; Kozaki H; Ohta N; Suzuki Y; Shimizu T
Nihon Jibiinkoka Gakkai Kaiho; 2015 Dec; 118(12):1429-35. PubMed ID: 26964395
[TBL] [Abstract][Full Text] [Related]
38. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
[TBL] [Abstract][Full Text] [Related]
39. Sublingual immunotherapy for Japanese cedar pollinosis.
Okubo K; Gotoh M
Allergol Int; 2009 Jun; 58(2):149-54. PubMed ID: 19390236
[TBL] [Abstract][Full Text] [Related]
40. Immunological parameters in prophylactic sublingual immunotherapy in asymptomatic subjects sensitized to Japanese cedar pollen.
Yamanaka K; Shah SA; Sakaida H; Yamagiwa A; Masuda S; Mizutani H; Takeuchi K
Allergol Int; 2015 Jan; 64(1):54-9. PubMed ID: 25605528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]